Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apple trial: Linaclotide vs sennoside before 1L PEG-ascorbic acid for colonoscopy bowel preparation
jRCTs051210162Completed
- Start
- Apr 2022
- Modality
- Peptides
- Countries
- 1
01
Overview
Randomised, single-blind trial of linaclotide in None (2 arms). Primary endpoint: Inadequate bowel preparation rate. Started Apr 2022; status: completed.
02
Drugs
linaclotide
Beyond the preview
Go deeper on jRCTs051210162.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051210162.